You have to be signed in to use this resource.
Delirium Management Advice for older patients with confirmed or suspected COVID-19
Older people are at particular risks of delirium, and delirium may be one of the symptoms of COVID-19. Hyperactive delirium may present particular challenges in the context of the COVID crisis. Standard non-pharmacological measures may not be possible in isolation environments. Isolation environments and PPE may worse symptoms of delirium. Risk of Harm to others may exceed risks to individuals and earlier use of pharmacological measures may be necessary. This papers includes guidance on prevention, detection, management and the use of sedating medication for severe agitation in patients with delirium and COVID-19.
Resource details
| Contributed by: | Delirium |
| Authored by: |
|
| Licence: | More information on licences |
| Last updated: | 29 December 2020 |
| First contributed: | 17 September 2020 |
| Audience access level: | Full user |
Share this resource
Report an issue with this resource
You may report a resource, for example, if there is an issue with copyright infringement, breach of personal data, factual inaccuracies, typing errors or safety concerns. The type of issue will determine whether the resource is immediately removed from the platform or if the contributor is asked to make amendments. You can report a resource from the resource information page or by contacting the Learning Hub support team.
You can contact the Learning Hub support team by completing the support form or if you have a general enquiry you can email enquiries@learninghub.nhs.uk.